Shandong Wohua Pharmaceutical Co Ltd (SHE:002107) — Market Cap & Net Worth
Market Cap & Net Worth: Shandong Wohua Pharmaceutical Co Ltd (002107)
Shandong Wohua Pharmaceutical Co Ltd (SHE:002107) has a market capitalization of $573.51 Million (CN¥3.92 Billion) as of May 23, 2026. Listed on the SHE stock exchange, this China-based company holds position #11926 globally and #3607 in its home market, demonstrating a -7.62% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shandong Wohua Pharmaceutical Co Ltd's stock price CN¥6.79 by its total outstanding shares 577209600 (577.21 Million). Analyse Shandong Wohua Pharmaceutical Co Ltd (002107) cash conversion ratio to see how efficiently the company converts income to cash.
Shandong Wohua Pharmaceutical Co Ltd Market Cap History: 2015 to 2026
Shandong Wohua Pharmaceutical Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $1.19 Billion to $573.51 Million (-6.09% CAGR).
Shandong Wohua Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shandong Wohua Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.65x
Shandong Wohua Pharmaceutical Co Ltd's market cap is 0.65 times its annual revenue
Latest Price to Earnings (P/E) Ratio
5.51x
Shandong Wohua Pharmaceutical Co Ltd's market cap is 5.51 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $760.57 Million | $562.85 Million | $48.81 Million | 1.35x | 15.58x |
| 2017 | $579.52 Million | $726.65 Million | $57.03 Million | 0.80x | 10.16x |
| 2018 | $304.50 Million | $774.42 Million | $45.65 Million | 0.39x | 6.67x |
| 2019 | $396.09 Million | $860.29 Million | $95.80 Million | 0.46x | 4.13x |
| 2020 | $601.05 Million | $1.01 Billion | $178.88 Million | 0.60x | 3.36x |
| 2021 | $571.38 Million | $942.67 Million | $163.39 Million | 0.61x | 3.50x |
| 2022 | $496.46 Million | $1.01 Billion | $107.39 Million | 0.49x | 4.62x |
| 2023 | $486.05 Million | $909.51 Million | $58.77 Million | 0.53x | 8.27x |
| 2024 | $403.74 Million | $763.79 Million | $36.40 Million | 0.53x | 11.09x |
| 2025 | $527.05 Million | $816.95 Million | $95.72 Million | 0.65x | 5.51x |
Competitor Companies of 002107 by Market Capitalization
Companies near Shandong Wohua Pharmaceutical Co Ltd in the global market cap rankings as of May 23, 2026.
Key companies related to Shandong Wohua Pharmaceutical Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #501 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #556 globally with a market cap of $47.77 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #563 globally with a market cap of $47.11 Billion USD ( CN¥321.95 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #615 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #501 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #556 | GALDERMA GROUP AG | NYSE:GALDY | $47.77 Billion | $40.73 |
| #563 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $47.11 Billion | CN¥50.47 |
| #615 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.90 |
Shandong Wohua Pharmaceutical Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Shandong Wohua Pharmaceutical Co Ltd's market cap moved from $1.19 Billion to $ 573.51 Million, with a yearly change of -6.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥573.51 Million | +8.81% |
| 2025 | CN¥527.05 Million | +30.54% |
| 2024 | CN¥403.74 Million | -16.93% |
| 2023 | CN¥486.05 Million | -2.10% |
| 2022 | CN¥496.46 Million | -13.11% |
| 2021 | CN¥571.38 Million | -4.94% |
| 2020 | CN¥601.05 Million | +51.75% |
| 2019 | CN¥396.09 Million | +30.08% |
| 2018 | CN¥304.50 Million | -47.46% |
| 2017 | CN¥579.52 Million | -23.80% |
| 2016 | CN¥760.57 Million | -35.89% |
| 2015 | CN¥1.19 Billion | -- |
End of Day Market Cap According to Different Sources
On May 23rd, 2026 the market cap of Shandong Wohua Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $573.51 Million USD |
| MoneyControl | $573.51 Million USD |
| MarketWatch | $573.51 Million USD |
| marketcap.company | $573.51 Million USD |
| Reuters | $573.51 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shandong Wohua Pharmaceutical Co Ltd
Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. The company produces and sells tablets, granules, capsules, oral liquid, and pills; medicinal herb cultivation; and provides pharmaceutical technology consulting services. It also offers products including drugs for cardiovascular, cerebrovascular, and nervous system diseases, such as Wohua Xinkeshu t… Read more